When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...

People who abandon popular GLP-1 weight loss medications like Ozempic put weight back on quickly, researchers say. A new ...

Protein is officially having its moment at restaurants nationwide. Dunkin’ is the latest chain to add protein to its menu, ...

Pharmaceutical company Novo Nordisk announced that a new pill-version of its GLP-1 weight-loss drug is now "broadly available ...

Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...

Some dietary supplements may help naturally boost GLP-1, but more research is needed to better understand their potential ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to ...

And in a phase III trial win, Foresee Pharmaceuticals said its long-acting gonadotropin-releasing hormone agonist leuprolide ...

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new ...

Among adolescents with asthma and overweight or obesity, the relative risk for acute asthma exacerbations was significantly reduced with GLP-1 receptor agonist use vs. nonpharmacological weight ...